Objectives-To determine the activity of glutathione transferase and to measure the S-methylcysteine adducts in blood proteins, after acute inhalational exposure to methyl bromide. To examine the influence of the polymorphism of glutathione-S-transferase 0 (GSTT1) on the neurotoxicity of methyl bromide. Methods-Two workers acutely exposed to methyl bromide with inadequate respiratory protective devices were poisoned. Seven weeks after the accident, blood samples were drawn from both patients, for measurement of glutathione transferase activity in erythrocytes (conjugator status-that is, GSTT1 phenotype) and measurement of binding products of methyl bromide with blood proteins. Conjugator status was determined by a standard procedure. The binding product of methyl bromide, S-methylcysteine, was measured in globin and albumin. Results-Duration and intensity of exposure were identical for both patients as they worked together with the same protective devices and with similar physical effort. However, one patient had very severe poisoning, whereas the other only developed mild neurotoxic symptoms. The first patient was a "conjugator" with normal glutathione transferase activity, whereas this activity was undetectable in the erythrocytes of the second patient, who consequently had higher concentrations of S-methylcysteine adduct in albumin (149 v 91 nmollg protein) and in globin (77 v 30 nmollg protein).
Accepted 6 October 1995 Abstract Objectives-To determine the activity of glutathione transferase and to measure the S-methylcysteine adducts in blood proteins, after acute inhalational exposure to methyl bromide. To examine the influence of the polymorphism of glutathione-S-transferase 0 (GSTT1) on the neurotoxicity of methyl bromide. Methods-Two workers acutely exposed to methyl bromide with inadequate respiratory protective devices were poisoned. Seven weeks after the accident, blood samples were drawn from both patients, for measurement of glutathione transferase activity in erythrocytes (conjugator status-that is, GSTT1 phenotype) and measurement of binding products of methyl bromide with blood proteins. Conjugator status was determined by a standard procedure. The binding product of methyl bromide, S-methylcysteine, was measured in globin and albumin. Results-Duration and intensity of exposure were identical for both patients as they worked together with the same protective devices and with similar physical effort. However, one patient had very severe poisoning, whereas the other only developed mild neurotoxic symptoms. The first patient was a "conjugator" with normal glutathione transferase activity, whereas this activity was undetectable in the erythrocytes of the second patient, who consequently had higher concentrations of S-methylcysteine adduct in albu- There are no reliable indicators of exposure to methyl bromide: methyl bromide is rapidly undetectable in human tissues, due to its short half life,39 concentrations of blood bromide and S-methylcysteine adduct are dependent on the metabolism of methyl bromide, which displays genetic polymorphism.'0 Conjugation with glutathione to S-methylglutathione is the first step of the major metabolic pathway for all methyl halides in various rodent species." '1 Conjugation of methyl bromide with glutathione is both non-enzymatic and catalysed by glutathione transferase in human erythrocytes. 14 This enzyme activity shows polymorphism.'0 Three quarters of the western European population are able to enzymatically conjugate methyl bromide with glutathione; the remaining quarter lacks this specific enzyme activity."' It was shown that methyl bromide induced sister chromatid exchanges in vitro in the lymphocytes of nonconjugators, whereas such an effect was not found in the lymphocytes of conjugators. '5 This indicates that the genotoxicity of methyl bromide is probably the consequence of the methylating activity of the parent compound and that conjugation to glutathione has a protective effect.
To date, the mechanism of methyl bromide neurotoxicity has not been elucidated. However, it is generally postulated that neurotoxic effects also result from direct alkylation of macromolecules; conjugation to glutathione is consequently thought to have a protective effect and giving N-acetylcysteine is recommended by some authors to prevent the acute systemic effects of methyl bromide. '6 We report an accident involving two workers, in whom the clinical and laboratory features do not support these propositions.
Patients and methods
The first patient was admitted to the intensive care unit of the Reims Poison Centre about four hours after the end of exposure. The second patient was referred to the Occupational Health and Clinical Toxicology Department of Fernand-Widal Hospital, four days after the accident.
The circumstances of the accident were obtained through interviews with the second poisoned worker.
Both 
Results

CIRCUMSTANCES OF THE ACCIDENT
The accident occurred in a nine floor mill. On day 1, the two workers sealed all openings except one door at the bottom of the building; they placed methyl bromide cylinders on each floor; then both of them, wearing canister respirators, opened the cylinders; they started from the upper floors and immediately went out of the building at the end of the operation which lasted less than 10 minutes, and then sealed the escape door.
They returned on day 2, about 24 hours after the beginning of fumigation. Protective clothing consisted of overalls, PVC gloves, working shoes and masks; as they thought the recommended airway protection was unnecessarily uncomfortable, they only wore face masks with disposable filters instead of the autonomous breathing apparatus which they should have used. At first, they removed seals and opened doors and windows on the ground floor. One of them then went up to the ninth floor and the other went to the eighth where they performed the same operation. They met at the seventh floor and then worked together, opening all windows on each floor, while going downstairs. The total operation lasted about 45 minutes. A sample of the atmosphere in the building had been taken at the very beginning of the ventilation procedure: the methyl bromide concentration was measured to be 17 000 mg/m3.
PATIENTS
On their return to the ground floor both workers noted a chloroform like odour through their mask and experienced a slight burning sensation in the throat which prompted them to leave the building, remove their protecting devices and clothes, and take a shower. A few minutes after the end of exposure, both workers experienced nausea, vomiting, headache, and dizziness. Two hours later, one of them (patient 1) had severe myoclonic seizures. Both patients were soon admitted to the nearest rural hospital. Patient 1 received thiopental and flunitrazepam, and was intubated and mechanically ventilated. Both patients were then transferred to the intensive care unit of the Reims poison centre.
Case 1 Patient 1 was a previously healthy 43 year old man. On admission, he showed generalised seizures, cardiogenic shock, bilateral pulmonary oedema, profuse diarrhoea, and acute anuric renal failure. As well as standard supportive measures, treatment with intravenous N-acetylcysteine was started five hours after the end of exposure: the initial dose of 140 mg/kg was followed by 5 g doses every four hours until the fifth day. Diarrhoea resolved spontaneously within 24 hours. Pulmonary oedema was rapidly controlled by permanent positive pressure ventilation. The haemodynamic disturbances required high doses of catecholamines for five days. Because of the unstable haemodynamic condition, continuous haemofiltration was initially performed for 13 days, then haemodialysis was performed daily for another 21 days; renal function no longer required dialysis thereafter. Measurements of plasma bromide concentrations were performed on admission and on the next day. The initial bromide concentration was 156 mg/l (normal range: 3-5-5 5 mg/i) and returned to normal values on the second day, after 12 hours of haemofiltration. Surprisingly, liver function tests remained normal throughout the acute phase of poisoning. Necrotic lesions of the skin appeared on the distal extremities of the fingers and toes in the first seven days after admission; moist dressings allowed complete healing within two weeks. The tonic clonic generalised convulsions were only partially controlled by repeated intravenous doses of clonazepam and thiopental; a few days after admission, they turned into generalised myoclonic jerks which required curarisation with pancuronium until the 21st day. Suppression of myoclonic activity was then achieved by long term treatment with carbamazepine and clonazepam. Mechanical ventilation was stopped on the 22nd day, but owing to absent gag reflex, the patient was finally extubated only on the 33rd day. He was discharged from the intensive care unit to a physical rehabilitation centre on the 52nd day. He still had ataxia and debilitating action/intention myoclonus, bilateral cortical deafness, and mental deterioration. One year later, his situation is unchanged and he is confined to a wheelchair. Serum bromide concentration was below the limit of detection. Neuropsychological tests were performed and showed impaired performance on memory tasks, especially those exploring immediate and verbal memory. Manual dexterity and reaction time were also impaired. Electroencephalography was normal. Interpeak latency I-V of brainstem auditory evoked potentials was bilaterally increased. Somatosensory and visual evoked potentials were normal. Electroneuromyography confirmed the mild distal motor neuropathy. On follow up, progressive recovery was reported by the patient and confirmed by tests: the distal motor neuropathy disappeared within six months, latencies of brainstem auditory evoked potentials returned to normal within 12 months. Neuropsychological tests also progressively improved: one year after the accident, they only showed a mild defect of verbal memory.
DETERMINATION OF CONJUGATOR STATUS
Measurement of binding products of methyl bromide with blood proteins The table shows the results of these investigations. The first patient was a conjugator, and the second was a non-conjugator. SMethylcysteine adducts were high in both albumin and globin and were higher in the second patient who was a non-conjugator.
Discussion
Conjugation with glutathione is the first step in the main metabolic pathway of monohalomethanes. '4 1819 Methylglutathione is then transformed into S-methylcysteine by transpeptidases. Further metabolism produces methanethiol through methylthioacetic acid. Oxidation of methanethiol generates formaldehyde and hydrogen sulphide which may be further oxidised into formate and sulphate respectively. "I Whether methyl bromide toxicity is due to direct alkylation of cellular components (primarily glutathione, then macromolecules) by the parent compound, or can be attributed to toxic metabolites such as methanethiol and formaldehyde has been extensively disputed for the past 10 years. Exposure to methyl bromide has induced glutathione depletion in various systems." [20] [21] [22] However, the significance of this finding is unclear, as shown by the conflicting results of experimental studies. On the one hand, glutathione depletion was found to increase methyl bromide toxicity in rats 21 and pretreatment of mice, rats, or rabbits with glutathione, cysteine, N-acetylcysteine, or methionine had a protective effect,2324 on the other hand, glutathione depletion before exposure inhibited toxicity of another monohalomethane, methyl chloride, in mice.25 These conflicting results may be explained by significant differences between species in the metabolism of monohalomethanes; such differences have been shown to exist-for example, glutathione transferase activity varies considerably from one species to another.'8 Methodological bias may be another explanation for these discrepancies: the doses and conditions of exposure varied considerably in the published studies.
Some clarification of the mechanism of methyl bromide toxicity was gained recently, when Hallier et al '5 showed that in vitro conjugation with glutathione protected human lymphocytes from the induction of sister chromatid exchanges caused by this halomethane. This indicates that the genotoxic effects are probably due to the parent compound.
The data presented here suggest a different mechanism for methyl bromide neurotoxicity. Indeed, these two workers experienced the same exposure to the fumigant for an identical duration and intensity, as they worked together and used the same protective devices. As they produced very similar physical efforts, it is highly probable that they absorbed amounts of methyl bromide which were not significantly different. However, one of them (patient 1) had very severe poisoning, whereas the other (patient 2) developed only mildly neurotoxic symptoms.
Glutathione transferase activity was measured in erythrocytes of both patients. The first patient was a conjugator: he possessed this specific enzyme activity, which was lacking in the erythrocytes of the second patient (a so called non-conjugator). The If the initial conjugation of methyl bromide with glutathione has a toxifying rather than a detoxifying effect, treatment with N-acetylcysteine, which has been proposed by some authors,'6 should be questioned. NAcetylcysteine is a precursor of glutathione. Indeed, if metabolites of S-methylglutathione are the ultimate toxic species, to give N-acetylcysteine could have both a toxifying and a detoxifying effect: it would increase the production of methanethiol and formaldehyde but would also accelerate neutralisation of formaldehyde,'2 which is one of the two probable ultimate toxic metabolites. Consequently, to give glutathione precursors could either increase or decrease methyl bromide neurotoxicity depending upon the conditions of exposure and the therapeutic protocol. Patient 1, who was a conjugator, received N-acetylcysteine, but this treatment did not have any obvious protective effect. From a practical point of view, the consequences of N-acetylcysteine being given to cases with methyl bromide poisoning should certainly be further investigated before it can be recommended as specific treatment.
